2026 NPPES data Hematology & Oncology Physician NPI 1972892750 M.D.
Verify on CMS →

JACQUELINE MALEKIRAD, M.D.

Hematology & Oncology Physician in LAGUNA HILLS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
582
Medicare Part D claims · 156 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.7426/100
▼ 6 pts below national avg 83.1 · [object Object]
Industry payments
$220.46
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JACQUELINE MALEKIRAD, M.D. reported a CMS MIPS final score of 76.7426/100 — below the 83.1 national average — and filed 582 Medicare Part D claims in 2023.

76.7426/100
MIPS score · -6 vs avg
582
Part D claims, 2023
81%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JACQUELINE MALEKIRAD, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

77 21st percentile higher than 21% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JACQUELINE MALEKIRAD, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JACQUELINE MALEKIRAD, M.D.?

Below national average

NPI registry status

Active

Issued 04/01/2011

NPI 1972892750

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

582 31% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

76.7426/100 6.357399999999998% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Hematology & Oncology Physician compares to other specialties among California providers

California providers

Hematology & Oncology Physician share within California

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within California

Medicare quality performance — MIPS

JACQUELINE MALEKIRAD, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
76.7426/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 76.7426/100 vs national avg 83.1

0%100%National avg83%76.7%
MIPS final score (Hematology & Oncology Physician) — 76.7426/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JACQUELINE MALEKIRAD, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 24411 HEALTH CENTER DR., STE 320, LAGUNA HILLS, CA, 92653, with a listed phone of (949) 380-2670. NPI 1972892750 was issued on 04/01/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MALEKIRAD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 582 prescription claims written by this provider, covering 156 Medicare beneficiaries and totaling roughly $699K in drug spend, split 19% brand-name and 81% generic by claim count, with an opioid prescribing rate of 2.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.7426/100 for the 2023 performance year (Quality 80.9479, Cost 55.1205), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

24411 HEALTH CENTER DR., STE 320
LAGUNA HILLS, CA 92653

Provider Details

NPI 1972892750
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 04/01/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.7426
Final Score
Avg: 83.1
80.9479
Quality
55.1205
Cost
78
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where JACQUELINE MALEKIRAD, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEMORIALCARE MEDICAL FOUNDATION
LAGUNA HILLS, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JACQUELINE MALEKIRAD, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$220

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JACQUELINE MALEKIRAD, M.D.. To verify JACQUELINE MALEKIRAD, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

JACQUELINE MALEKIRAD, M.D. — brand share 19.0%
Specialty average (est.)

19% brand-name claims vs 81% generic, on 582 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

582
Total Claims
$699K
Total Drug Cost
156
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
982
Total Day Supply
27,749
Brand vs Generic
19% brand / 81% generic
Brand Drug Cost
$605K
Generic Drug Cost
$94K
Opioid Claims
12 (2.1% rate)

Patient Demographics

Average Patient Age
75.9 years
Avg HCC Risk Score
2.15
Gender Split
76% female / 24% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JACQUELINE MALEKIRAD, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
186
Letrozole
71
Xarelto
Rivaroxaban
34
Ondansetron Odt
Ondansetron
28
Folic Acid
26
Tamoxifen Citrate
26
Eliquis
Apixaban
23
Prednisone
20
Tagrisso
Osimertinib Mesylate
13
Alendronate Sodium
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How JACQUELINE MALEKIRAD, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

JACQUELINE MALEKIRAD, M.D.'s 582 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as MALEKIRAD.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JACQUELINE MALEKIRAD, M.D.'s specialty?
JACQUELINE MALEKIRAD, M.D. specializes in Hematology & Oncology Physician and practices in LAGUNA HILLS, California. Credentials: M.D..
How much does JACQUELINE MALEKIRAD, M.D. prescribe under Medicare Part D?
In 2023, JACQUELINE MALEKIRAD, M.D. wrote 582 Medicare Part D claims totaling $699K in drug costs for 156 beneficiaries.
What is JACQUELINE MALEKIRAD, M.D.'s Medicare quality score?
JACQUELINE MALEKIRAD, M.D. has a CMS MIPS Final Score of 76.7426/100 (Quality: 80.9479, Cost: 55.1205). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JACQUELINE MALEKIRAD, M.D. located?
JACQUELINE MALEKIRAD, M.D. is located at 24411 HEALTH CENTER DR., STE 320, LAGUNA HILLS, CA, 92653. Phone: (949) 380-2670.
What is JACQUELINE MALEKIRAD, M.D.'s NPI number?
JACQUELINE MALEKIRAD, M.D.'s National Provider Identifier (NPI) is 1972892750, issued on 04/01/2011.
Does JACQUELINE MALEKIRAD, M.D. prescribe more brand-name or generic drugs?
JACQUELINE MALEKIRAD, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $605K in brand drug costs.
Does JACQUELINE MALEKIRAD, M.D. prescribe opioids?
Yes, JACQUELINE MALEKIRAD, M.D. had 12 opioid claims in 2023 with an opioid prescribing rate of 2.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does JACQUELINE MALEKIRAD, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JACQUELINE MALEKIRAD, M.D.'s most frequently prescribed drugs include Anastrozole, Letrozole, Xarelto. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JACQUELINE MALEKIRAD, M.D. accept Medicare?
JACQUELINE MALEKIRAD, M.D. appears in CMS Medicare data with 582 Part D claims and 156 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JACQUELINE MALEKIRAD, M.D.'s credentials?
JACQUELINE MALEKIRAD, M.D.'s NPI is 1972892750 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology